Inventor
TANIGUCHI TAKAHIKO
JP28 patents
⚠️ This page may combine multiple inventors who share the name “TANIGUCHI TAKAHIKO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
TANIGUCHI TAKAHIKO
10 patentsUS8916566B2Dec 23, 2014
Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
TANIGUCHI TAKAHIKO4 citations83
US8513251B2Aug 20, 2013
Pyridazinone compounds
TANIGUCHI TAKAHIKO6 citations83
US8435995B2May 7, 2013
Pyridazinone compounds
TANIGUCHI TAKAHIKO6 citations83
US8778944B2Jul 15, 2014
Pyridazinone compounds
TANIGUCHI TAKAHIKO5 citations82
US9150588B2Oct 6, 2015
Substituted pyridazin-4(1H)-ones as phosphodiesterase 10A inhibitors
TANIGUCHI TAKAHIKO5 citations72
US8846713B2Sep 30, 2014
Fused heterocyclic compounds as phosphodiesterases (PDEs) inhibitors
TANIGUCHI TAKAHIKO2 citations61
US8563575B2Oct 22, 2013
Fused heterocyclic compounds
TANIGUCHI TAKAHIKO4 citations60
US9029388B2May 12, 2015
Condensed heterocyclic compound
TANIGUCHI TAKAHIKO1 citations50
US9579407B2Feb 28, 2017
Radiolabeled compounds and their use as radiotracers for quantitative imaging of phosphodiesterase (PDE10A) in mammals
TANIGUCHI TAKAHIKO1 citations45
US8575167B2Nov 5, 2013
Spiro compounds having stearoyl-CoA desaturase action
TANIGUCHI TAKAHIKO0 citations41
TAKEDA PHARMACEUTICALS CO
5 patentsUS9550756B2Jan 24, 2017
Pyridazinone compounds as phosphodiesterase inhibitors and methods of treating disorders
TAKEDA PHARMACEUTICALS CO2 citations72
US9527841B2Dec 27, 2016
Substituted pyrido[2,3-b]pyrazines as phosphodiesterase 2A inhibitors
TAKEDA PHARMACEUTICALS CO2 citations58
US9944596B2Apr 17, 2018
Heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations51
US10017508B2Jul 10, 2018
Nitrogenated heterocyclic compound
TAKEDA PHARMACEUTICALS CO0 citations50
US9469637B2Oct 18, 2016
Nitrogenated heterocyclic compound
TAKEDA PHARMACEUTICALS CO1 citations50
TAKEDA PHARMACEUTICAL
4 patentsUS8354411B2Jan 15, 2013
1-phenyl-3-pyrazolylpyridazin-4(1H)-one compound
TAKEDA PHARMACEUTICAL9 citations92
US8940758B2Jan 27, 2015
Fused heterocyclic compounds
TAKEDA PHARMACEUTICAL2 citations62
US9226921B2Jan 5, 2016
Fused heterocyclic compounds as phosphodiesterases (PDES) inhibitors
TAKEDA PHARMACEUTICAL2 citations61
US7803822B2Sep 28, 2010
Triazole derivative and use thereof
TAKEDA PHARMACEUTICAL6 citations60
CHISSO CORP
3 patentsUS6437133B1Aug 20, 2002
Method of catalytically removing a protective group containing an allyl group using a reducing agent
CHISSO CORP1 citations52
US6313353B1Nov 6, 2001
Method for producing an optically active acyloin
CHISSO CORP0 citations52
US5900369AMay 4, 1999
Method for producing oxodicyclopentadiene
CHISSO CORP0 citations52